84 related articles for article (PubMed ID: 3499879)
1. The chemotherapy of rodent malaria XLI. Causal prophylaxis. Part V. Effect of mefloquine on exoerythrocytic schizogony in Plasmodium yoelii yoelii.
Boulard Y; Landau I; Miltgen F; Peters W; Ellis DS
Ann Trop Med Parasitol; 1986 Dec; 80(6):577-80. PubMed ID: 3499879
[TBL] [Abstract][Full Text] [Related]
2. [Study on the exoerythrocytic forms of Plasmodium yoelii yoelii in rats and mice].
Zhang JX; Lin BY; Pan YR
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1990; 8(4):288-90. PubMed ID: 2099260
[TBL] [Abstract][Full Text] [Related]
3. The chemotherapy of rodent malaria, XXXIV. Causal prophylaxis Part III: Ultrastructural changes induced in exo-erythrocytic schizonts of Plasmodium yoelii yoelii by primaquine.
Boulard Y; Landau I; Miltgen F; Ellis DS; Peters W
Ann Trop Med Parasitol; 1983 Dec; 77(6):555-68. PubMed ID: 6140901
[TBL] [Abstract][Full Text] [Related]
4. [Retarded schizogony of Plasmodium yoelii yoelii in rodents treated with ethionine or subjected to a methionine deficiency: histological and ultrastructural studies].
Landau I; Boulard Y; Seureau C; Peters W
Ann Parasitol Hum Comp; 1982; 57(1):1-20. PubMed ID: 7081885
[TBL] [Abstract][Full Text] [Related]
5. Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis.
Awasthi A; Dutta GP; Bhakuni V; Tripathi R
Exp Parasitol; 2004; 107(3-4):115-9. PubMed ID: 15363936
[TBL] [Abstract][Full Text] [Related]
6. The chemotherapy of rodent malaria XXXVI. Part IV. The activity of a new 8-aminoquinoline, WR 225,448 against exo-erythrocytic schizonts of Plasmodium yoelii yoelii.
Peters W; Ellis D; Boulard Y; Landau I
Ann Trop Med Parasitol; 1984 Oct; 78(5):467-78. PubMed ID: 6524991
[TBL] [Abstract][Full Text] [Related]
7. The chemotherapy of rodent malaria. XLIV. Studies on the mode of action of CM 6606, an indolo (3,2-c) quinoline N-oxide.
Peters W; Robinson BL; Mutambu SL; Warhurst DC; Ellis DS; Tovey DG
Ann Trop Med Parasitol; 1989 Feb; 83(1):1-10. PubMed ID: 2688575
[TBL] [Abstract][Full Text] [Related]
8. [Morphological characteristics of Plasmodium yoelii schizonts in ghost erythrocytes].
Mao YH; Xu B; Liu BF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):263-7. PubMed ID: 15266827
[TBL] [Abstract][Full Text] [Related]
9. Effect of ketotifen on the ultrastructure of the erythrocytic stages of Plasmodium yoelii.
Cao HM; Pan XQ
Southeast Asian J Trop Med Public Health; 1990 Dec; 21(4):545-51. PubMed ID: 2098914
[TBL] [Abstract][Full Text] [Related]
10. A plant-derived morphinan as a novel lead compound active against malaria liver stages.
Carraz M; Jossang A; Franetich JF; Siau A; Ciceron L; Hannoun L; Sauerwein R; Frappier F; Rasoanaivo P; Snounou G; Mazier D
PLoS Med; 2006 Dec; 3(12):e513. PubMed ID: 17194195
[TBL] [Abstract][Full Text] [Related]
11. The chemotherapy of rodent malaria. LII. Response of Plasmodium yoelii ssp. NS to mefloquine and its enantiomers.
Peters W; Robinson BL; Mittelholzer ML; Crevoisier C; Stürchler D
Ann Trop Med Parasitol; 1995 Oct; 89(5):465-8. PubMed ID: 7495359
[TBL] [Abstract][Full Text] [Related]
12. The chemotherapy of rodent malaria, XXXVII. The in vivo action of two Mannich bases, WR 194,965 and WR 228,258 and an 8-aminoquinoline WR 225,448.
Peters W; Robinson BL
Ann Trop Med Parasitol; 1984 Dec; 78(6):561-5. PubMed ID: 6532327
[TBL] [Abstract][Full Text] [Related]
13. Improved transfection and new selectable markers for the rodent malaria parasite Plasmodium yoelii.
Jongco AM; Ting LM; Thathy V; Mota MM; Kim K
Mol Biochem Parasitol; 2006 Apr; 146(2):242-50. PubMed ID: 16458371
[TBL] [Abstract][Full Text] [Related]
14. Effects of nitroquine on ultrastructures and cytochrome oxidase of exoerythrocytic Plasmodium yoelii in rat liver.
Chen XH; Hu YM; Liao YQ; Ke JX; Zhang WJ
Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):390-3. PubMed ID: 10375793
[TBL] [Abstract][Full Text] [Related]
15. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
Ishih A; Miyase T; Ohori K; Terada M
Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
[TBL] [Abstract][Full Text] [Related]
16. The chemotherapy of rodent malaria, XXIII Causal prophylaxis, part II: Practical experience with Plasmodium yoelii nigeriensis in drug screening.
Peters W; Davies EE; Robinson BL
Ann Trop Med Parasitol; 1975 Sep; 69(3):311-28. PubMed ID: 1098590
[TBL] [Abstract][Full Text] [Related]
17. Effect of Plasmodium yoelii nigeriensis infection on hepatic and splenic glutathione-S-transferase(s) in Swiss albino and db/+ mice: efficacy of mefloquine and menadione in antimalarial chemotherapy.
Ahmad R; Srivastava AK
Parasitology; 2007 Jul; 134(Pt 7):931-8. PubMed ID: 17352848
[TBL] [Abstract][Full Text] [Related]
18. A Plasmodium yoelii Mei2-Like RNA Binding Protein Is Essential for Completion of Liver Stage Schizogony.
Dankwa DA; Davis MJ; Kappe SHI; Vaughan AM
Infect Immun; 2016 May; 84(5):1336-1345. PubMed ID: 26883588
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial dehydrogenases in the aerobic respiratory chain of the rodent malaria parasite Plasmodium yoelii yoelii.
Kawahara K; Mogi T; Tanaka TQ; Hata M; Miyoshi H; Kita K
J Biochem; 2009 Feb; 145(2):229-37. PubMed ID: 19060309
[TBL] [Abstract][Full Text] [Related]
20. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
